Leventakos, K., Dimou, A., Foster, N., Jaszewski, B. L., Mansfield, A. S., Parikh, K., Lensing, J., Flickinger, L. M., Smith, K. E. R., Behl, D., Shanshal, M., Schwecke, A. J., Luce, A., Moffett, J. N., Potter, A., Al-Ajmi, A., Dick, K., Weinmann, D., Molina, J. R., Adjei, A. A. (2026). MC1923: Phase II durvalumab plus lurbinectedin in platinum-resistant relapsed extensive-stage small cell lung cancer after prior chemoimmunotherapy (cohort B).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8094